Thursday, October 20, 2022 |
|
| 2:00 – 9:00 PM | REGISTRATION |
| 6:00 – 8:15 PM | PRE-CONGRESS Workshop
INTERNATIONAL COLLABORATION IN CAYA NHL OUTSIDE NORTH AMERICA AND WESTERN EUROPE Guillermo Chantada, MD, Argentina & Catherine Patte, MD, France |
| 6:00 – 6:20 PM | INTERNATIONAL COLLABORATION: THE SIOP PERSPECTIVE
Guillermo Chantada, MD, Argentina |
| 6:20 – 6:40 PM | INTERNATIONAL COLLABORATION: THE CHINESE CHILDREN’S LYMPHOMA CONSORTIUM
Yonghong Zhang, MD, PhD, China |
| 6:40 – 7:00 PM | INTERNATIONAL COLLABORATION: THE FRANCO-AFRICIAN PEDIATRIC ONCOLOGY GROUP (GFAOP) PERSPECTIVE
M’hamed Harif, MD, Morocco (Tentative) |
| 7:00 – 7:15 PM | ABSTRACT #1 |
| 7:15 – 7:30 PM | ABSTRACT #2 |
| 7:30 – 7:45 PM | ABSTRACT #3 |
| 7:45 – 8:15 PM | PANEL DISCUSSION – ALL OF THE ABOVE |
Friday, October 21, 2022 |
|
| 7:00 AM – 5:00 PM | REGISTRATION |
| 8:00 – 8:10 AM | OPENING CEREMONY
Mitchell S. Cairo, MD, Chair, USA |
| 8:10 – 9:00 AM | ANGELO ROSOLEN, MD MEMORIAL LECTURE |
| 8:10 – 8:15 AM | INTRODUCTION
Marta Pillon, MD, Italy, & Lara Mussolin, PhD, Italy |
| 8:15 – 8:20 AM | INTRODUCTION FOR CATHERINE PATTE, MD, FRANCE
Laurence Brugieres, MD, France |
| 8:20 – 8:35 AM | IN B-CELL LYMPHOMA: SUCCESSFUL COLLABORATION BETWEEN EUROPE AND NORTH AMERICA. WHAT KIND OF PARTNERSHIP WITH AFRICA?
Catherine Patte, MD, France |
| 8:35 – 8:40 AM | INTRODUCTION FOR SHERRIE PERKINS, MD, PhD, USA
Megan Lim, MD, PhD, USA |
| 8:40 – 8:55 AM | THE ROLE OF PATHOLOGY IN SHAPING TREATMENT FOR PEDIATRIC NHL: A 25 YEAR PERSPECTIVE
Sherrie Perkins, MD, PhD, USA |
| 9:00 – 10:45 AM | PLENARY SESSION I – MATURE B-CELL NHL
Moderators: Stanton Goldman, MD, USA & Veronique Minard-Colin, MD, PhD, France |
| 9:00 – 9:20 AM | RITUXIMAB IMPROVES OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADVANCE STAGE MATURE B-NHL
Veronique Minard-Colin, MD, PhD, France |
| 9:20 – 9:40 AM | RITUXIMAB LOWERS THE CHEMOTHERAPY BURDEN IN CHILDREN AND ADOLESCENTS WITH LIMITED STAGE MATURE B-NHL
Stanton Goldman, MD, USA |
| 9:40 – 10:00 AM | MUTATIONAL LANDSCAPE IN PEDIATRIC BURKITT-LIKE LYMPHOMA (BLL) WITH 11q ABERRATION
Reiner Siebert, MD, Germany |
| 10:00 – 10:10 AM | ABSTRACT #1 |
| 10:10 – 10:20 AM | ABSTRACT #2 |
| 10:20 – 10:30 AM | ABSTRACT #3 |
| 10:30 – 10:45 AM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 10:45 – 11:00 AM | COFFEE BREAK |
| 11:00 – 12:45 PM | PLENARY SESSION II – LYMPHOMA TRANSLATIONAL BIOLOGY (DEDICATED IN MEMORY TO WARREN SANGER, PhD)
Moderators: Lara Mussolin, PhD, Italy & Wolfram Klapper, MD, Germany |
| 11:00 – 11:20 AM | PRECISION MEDICINE IN ADULT LYMPHOMA
Keynote Speaker # 1– Louis Staudt, MD, PhD, USA |
| 11:20 – 11:40 AM | EMERGING EPIGENETIC MODULATING THERAPIES IN NHL
Ari Melnick, MD, USA |
| 11:40 – 12:00 PM | INTEGRATIVE GENOMIC ANALYSIS OF PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA
Birgit Burkhardt, MD, PhD, Germany |
| 12:00 – 12:10 PM | ABSTRACT #1 |
| 12:10 – 12:20 PM | ABSTRACT #2 |
| 12:20 – 12:30 PM | ABSTRACT #3 |
| 12:30 – 12:45 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS (non-CME event) |
| 12:45 – 1:00 PM | PICK UP LUNCH |
| 1:00 – 1:45 PM | LUNCH SYMPOSIUM |
| 1:45 – 2:15 PM | COFFEE BREAK |
| 2:15 – 4:15 PM | PLENARY SESSION III – RARE NON-HODGKIN LYMPHOMA
Moderators – Ana Xavier, MD, USA & Yonghong Zhang, MD, PhD, China |
| 2:15 – 2:35 PM | NEW THERAPEUTIC APPROACHES TO ADVANCED NK/T-CELL LYMPHOMA
Ana Xavier, MD, USA |
| 2:35 – 2:55 PM | PEDIATRIC-TYPE FOLLICULAR LYMPHOMA (PTFL) and MARGINAL ZONE LYMPHOMA (MZL)
Karin Mellgren, MD, Sweden |
| 2:55 – 3:15 PM | EBV, HLH AND THE ASSOCIATED SPECTRUM OF T/NK-CELL LYMPHOPROLIFERATION
Nader El-Mallawany, MD, USA |
| 3:15 – 3:25 PM | ABSTRACT #1 |
| 2:25 – 3:35 PM | ABSTRACT #2 |
| 3:35 – 3:45 PM | ABSTRACT #3 |
| 3:45 – 3:55 PM | ABSTRACT #4 |
| 3:55 – 4:15 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 4:15 – 4:30 PM | COFFEE BREAK |
| 4:30 – 6:15 PM | PLENARY SESSION IV – IMMUNOLOGY, CELL THERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION
Moderators: Amos Burke, MD, UK & Wilhelm Woessmann, MD, Germany |
| 4:30 – 4:50 PM | PAST, PRESENT AND FUTURE OF CAR T-CELLS
Keynote Speaker #2 – Carl June, MD, USA |
| 4:50 – 5:10 PM | IMMUNE RESPONSE TO ALK IN ALK-POSITIVE LYMPHOMAS
Wilhelm Woessmann, MD, Germany |
| 5:10 – 5:30 PM | NOVEL IMMUNOTHERAPEUTICS
Mitchell S. Cairo, MD, USA |
| 5:30 – 5:40 PM | ABSTRACT #1 |
| 5:40 – 5:50 PM | ABSTRACT #2 |
| 5:50 – 6:00 PM | ABSTRACT #3 |
| 6:00 – 6:15 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 6:15 – 7:45 PM | WELCOME RECEPTION & POSTER VEIWING (ALL REGISTRANTS) |
Saturday, October 22, 2022
|
|
| 7:00 AM – 5:00 PM | REGISTRATION |
| 7:00 – 7:45 AM | BREAKFAST SYMPOSIUM – TBD |
| 7:45 – 8:30 AM | MEET THE PROFESSORS (Choose One Session) |
| Session 1 | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
Thomas Gross, MD, PhD, USA |
| Session 2 | ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): THE EUROPEAN PERSPECTIVE
Laurence Brugieres, MD, France |
| Session 3 | NK/T CELL LYMPHOMAS: THE JAPANESE PRESPECTIVE
Ritsuro Suzuki, MD, PhD, Japan |
| Session 4 | MINIMAL DISSEMINATED DISEASE AND MINIMAL RESIDUAL DISEASE DETECTION
Christine Damm-Welk, PhD, Germany |
| Session 5 | MOLECULAR-BASED THERAPEUTIC APPROACHES TO LANGERHANS CELL HISTIOCYTOSIS
Carl Allen, MD, PhD, USA |
| 8:30 – 10:15 AM | PLENARY SESSION V – ADOLESCENT AND YOUNG ADULT HODGKIN AND NON-HODGKIN LYMPHOMA
Moderators – Owen Smith, MA, MB, Ireland & Michael Link, MD, USA |
| 8:30 – 8:50 AM | PATHOBIOLOGY AND NOVEL APPROACHES TO PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBL)
Lisa Giulino-Roth, MD, USA |
| 8:50 – 9:10 AM | OUTCOME OF AYA PATIENTS WITH MATURE B-CELL LYMPHOMA TREATED ON PEDIATRIC INSPIRED PROTOCOLS
Sarah Alexander, MD, Canada |
| 9:10 – 9:30 AM | OUTCOME OF AYA vs CHILDHOOD NHL: THE IRISH EXPERIENCE
Owen Smith, MA, MB, Ireland |
| 9:30 – 9:40 AM | ABSTRACT #1 |
| 9:40 – 9:50 AM | ABSTRACT #2 |
| 9:50 – 10:00 AM | ABSTRACT #3 |
| 10:00 – 10:15 AM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 10:15 – 10:30 AM | COFFEE BREAK |
| 10:30 – 12:15 PM | PLENARY SESSION VI – SURVIVORSHIP AND LATE EFFECTS
Moderators – Matthew Ehrhardt, MD, USA & Jessica Hochberg, MD, USA |
| 10:30 – 10:50 AM | LATE HEALTH OUTCOMES IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NHL
Matthew Ehrhardt, MD, USA |
| 10:50 – 11:10 AM | SECOND MALIGNANCY AFTER TREATMENT IN CHILDREN AND ADOLESCENTS WITH NHL
Marta Pillon, MD, Italy |
| 11:10 – 11:30 AM | FERTILITY AND SEXUALITY IN CHILDHOOD AND ADOLESCENT NHL SURVIVORS
Jennifer Levine, MD, USA |
| 11:30 – 11:40 AM | ABSTRACT #1 |
| 11:40 – 11:50 AM | ABSTRACT #2 |
| 11:50 – 12:00 PM | ABSTRACT #3 |
| 12:00 – 12:15 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS (non-CME event) |
| 12:15 – 12:30 PM | PICK UP LUNCH |
| 12:30 – 1:15 PM | LUNCH SYMPOSIUM (TBD) |
| 1:15 – 1:45 PM | COFFEE BREAK |
| 1:45 – 3:45 PM | PLENARY SESSION VII – NOVEL THERAPEUTICS
Moderators – Lara Mussolin, PhD, Italy & Carl Allen, MD, PhD, USA |
| 1:45 – 2:05 PM | ALK INHIBITOR THERAPY IN ALCL
Masahiro Sekimizu, MD, Japan |
| 2:05 – 2:25 PM | TARGETING THE P13K/AKT/MTOR PATHWAY
Matthew Barth, MD, USA |
| 2:25 – 2:45 PM | EXOSOMES IN NHL OF CHILDHOOD: SMALL VESICLES WITH A GREAT POWER
Lara Mussolin, PhD, Italy |
| 2:24 – 2:55 PM | ABSTRACT #1 |
| 2:55 – 3:05 PM | ABSTRACT #2 |
| 3:35 – 3:15 PM | ABSTRACT #3 |
| 3:15 – 3:25 PM | ABSTRACT #4 |
| 3:25 – 3:45 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 3:45 – 4:00 PM | COFFEE BREAK |
| 4:00 – 6:00 PM | PLENARY SESSION VIII – POSTER DISCUSSION
Moderators – Paul Galardy, MD, USA; Birgit Burkhardt, MD, PhD, Germany; Laurence Brugieres, MD, France; & Itziar Salaverria, PhD, Spain |
Sunday, October 23, 2022 |
|
| 7:00 AM – 1:00 PM | REGISTRATION |
| 7:00 – 7:45 AM | BREAKFAST SYMPOSIUM – TBD |
| 7:45 – 8:30 AM | MEET THE PROFESSORS (CHOOSE ONE SESSION) |
| Session 1 | HEMATOPATHOLGY: WHAT’S NEW IN 2022
Rodney Miles, MD, PhD, USA |
| Session 2 | MENTORING YOUNG INVESTIGATORS IN CHILDHOOD AND ADOLESCENT NHL: THE COG EXPERIENCE
Birte Wistinghausen, MD, USA |
| Session 3 | CLINICAL/PATHOLOGICAL SPECTRUM OF PRIMARY CUTANEOUS LYMPHOMA
Ilske Oschlies, MD, Germany |
| 8:30 – 10:00 AM | PLENARY SESSION IX – BEST ORAL ABSTRACTS IN CHILDHOOD, ADOLESCENT AND YOUNG ADULT NHL
Moderators – Mitchell S. Cairo, MD, USA, Catherine Patte, MD, France & Sherrie Perkins, MD, PhD, USA |
| 8:30 – 8:45 AM | Abstract #1 |
| 8:45 – 9:00 AM | Abstract #2 |
| 9:00 – 9:15 AM | Abstract #3 |
| 9:15 – 9:30 AM | Abstract #4 |
| 9:30 – 9:45 AM | Abstract #5 |
| 9:45 – 10:00 AM | Abstract #6 |
| 10:00 – 10:15 AM | COFFEE BREAK |
| 10:15 – 12:00 PM | PLENARY SESSION X – ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) AND LYMPHOBLASTIC LYMPHOMA (LL)
Moderators – Suzanne Turner, PhD, UK & Michelle Hermiston, MD, PhD, USA |
| 10:15 – 10:35 AM | BRENTUXIMAB VEDOTIN IN CHILDHOOD ALCL
Eric Lowe, MD, USA |
| 10:35 – 10:55 AM | ALTERATIONS IN SIGNALING PATHWAYS LEADS TO RESISTANCE IN ALCL
Suzanne Turner, PhD, UK |
| 10:55 – 11:15 AM | NOVEL TARGETS IN T-LYMPHOBLASTIC LYMPHOMA
David Teachey, MD, USA |
| 11:15 – 11:35 AM | INNOVATIVE APPROACHES TO DETECT MDD/MRD IN ANAPLASTIC LARGE CELL LYMPHOMA AND LYMPHOBLASTIC LYMPHOMA
Megan Lim, MD, PhD, USA |
| 11:35 – 11:45 AM | ABSTRACT #1 |
| 11:45 – 11:55 AM | ABSTRACT #2 |
| 11:55 – 12:05 PM | ABSTRACT #3 |
| 12:05 – 12:20 PM | PANEL DISCUSSION AND QUESTIONS & ANSWERS |
| 12:20 – 12:30 PM | AWARDS SESSION BEST ORAL ABSTRACT, BEST POSTER DISCUSSION ABSTRACT
& BEST POSTER ABSTRACT
Award Committee – Stanton Goldman, MD, USA, and Ronit Elhasid, MD, Israel (Vice Chairs) Anthony Audino, MD, USA; M. Tezer Kutluk, MD, PhD, Turkey; and Vikki Rand, PhD, UK |
| 12:30 – 12:45 PM | CLOSING REMARKS
Mitchell S. Cairo, MD, Chair, USA |